Officials from Waycen and MegaMind during agreement signing ceremony. Credit: PRNewswire/Waycen.

Waycen has entered a strategic sales agreement with MegaMind, a healthcare company in the Middle East, for artificial intelligence (AI) medical solutions.

The partnership will see the introduction of Waycen’s AI gastrointestinal endoscopy software, ‘WAYMED Endo’, and AI respiratory self-screening service, ‘WAYMED Cough’, to the Middle Eastern medical market.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Waycen will leverage MegaMind IT Solution’s extensive network in this region.

Saudi Arabia-based MegaMind has a network of 13 group hospitals and digital projects with more than 40 healthcare institutions.

The collaboration is expected to enhance digital innovation in healthcare across the region, with MegaMind annually establishing up to 25 data centres for hospitals and supporting remote consultations and medical data digitalisation.

See Also:

Waycen CEO Kim Kyungnam said: “With this agreement, MegaMind’s 13 hospitals in the Middle East will start utilising the artificial intelligence gastrointestinal endoscopy software, WAYMED Endo, within the year.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the agreement encompasses a joint effort in developing future product lineups. This marks a significant export opportunity for K-Medical AI products in the Middle Eastern healthcare sector, which is experiencing rapid growth.

MegaMind CEO Hamza Batterjee said: “MegaMind has a mission and confidence to lead digital innovation in the Middle East healthcare market.”

WAYMED Endo from Waycen is a medical device software designed to assess real-time AI gastrointestinal endoscopy images.

It is compatible with endoscopes from various manufacturers, including Olympus, Fujifilm, and Pentax.

The device secured certification as a breakthrough device from the Ministry of Food and Drug Safety in South Korea.

WAYMED Cough is designed to assess the respiratory, coughing and vocal sounds of the users, through AI comprehensively. It also helps in self-screening respiratory health in daily life.